Joseph M. Obeid

597 total citations
13 papers, 371 citations indexed

About

Joseph M. Obeid is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Joseph M. Obeid has authored 13 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Immunology and 4 papers in Surgery. Recurrent topics in Joseph M. Obeid's work include Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Joseph M. Obeid is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Joseph M. Obeid collaborates with scholars based in United States, Qatar and Switzerland. Joseph M. Obeid's co-authors include Craig L. Slingluff, Donna H. Deacon, Yinin Hu, Gulsun Erdag, Timothy N. J. Bullock, Mark E. Smolkin, James W. Patterson, Mouadh Benamar, Tarek Abbas and Fadila Guessous and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Immunology Immunotherapy and EBioMedicine.

In The Last Decade

Joseph M. Obeid

12 papers receiving 367 citations

Peers

Joseph M. Obeid
Chanthirika Ragulan United Kingdom
Sadaf Mehdizadeh United States
Lisanne Noordam Netherlands
George Locke United States
Joseph M. Obeid
Citations per year, relative to Joseph M. Obeid Joseph M. Obeid (= 1×) peers Yusaku Watanabe

Countries citing papers authored by Joseph M. Obeid

Since Specialization
Citations

This map shows the geographic impact of Joseph M. Obeid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph M. Obeid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph M. Obeid more than expected).

Fields of papers citing papers by Joseph M. Obeid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph M. Obeid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph M. Obeid. The network helps show where Joseph M. Obeid may publish in the future.

Co-authorship network of co-authors of Joseph M. Obeid

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph M. Obeid. A scholar is included among the top collaborators of Joseph M. Obeid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph M. Obeid. Joseph M. Obeid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Obeid, Joseph M., Ileana S. Mauldin, Ryan D. Gentzler, et al.. (2024). Spatial colocalization and combined survival benefit of natural killer and CD8 T cells despite profound MHC class I loss in non-small cell lung cancer. Journal for ImmunoTherapy of Cancer. 12(9). e009126–e009126. 3 indexed citations
2.
Obeid, Joseph M., et al.. (2022). Atrial fibrillation in mechanical circulatory support patients. Vessel Plus. 6. 43–43.
3.
Kunk, Paul R., Sean C. Dougherty, Kevin Lynch, et al.. (2021). Myeloid Cell Infiltration Correlates With Prognosis in Cholangiocarcinoma and Varies Based on Tumor Location. Journal of Immunotherapy. 44(7). 254–263. 7 indexed citations
4.
Leick, Katie M., Joseph M. Obeid, Stefan Bekiranov, & Craig L. Slingluff. (2019). Systems analysis of barrier molecule and ARNT-related gene expression regulation in melanoma. OncoImmunology. 8(12). e1665978–e1665978. 7 indexed citations
5.
Kunk, Paul R., Joseph M. Obeid, Patcharin Pramoonjago, et al.. (2018). Mismatch repair deficiency in cholangiocarcinoma.. Journal of Clinical Oncology. 36(4_suppl). 269–269. 8 indexed citations
6.
Obeid, Joseph M., Paul R. Kunk, Victor M. Zaydfudim, et al.. (2017). Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time?. Cancer Immunology Immunotherapy. 67(2). 161–174. 20 indexed citations
7.
Obeid, Joseph M., Yinin Hu, Gulsun Erdag, Katie M. Leick, & Craig L. Slingluff. (2017). The heterogeneity of tumor-infiltrating CD8+ T cells in metastatic melanoma distorts their quantification: how to manage heterogeneity?. Melanoma Research. 27(3). 211–217. 18 indexed citations
8.
Obeid, Joseph M., Nolan A. Wages, Yinin Hu, Donna H. Deacon, & Craig L. Slingluff. (2016). Heterogeneity of CD8+ tumor-infiltrating lymphocytes in non-small-cell lung cancer: impact on patient prognostic assessments and comparison of quantification by different sampling strategies. Cancer Immunology Immunotherapy. 66(1). 33–43. 33 indexed citations
9.
Bedognetti, Davide, Ileana S. Mauldin, Donna H. Deacon, et al.. (2016). Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk. OncoImmunology. 5(12). e1240857–e1240857. 51 indexed citations
10.
Obeid, Joseph M., Gulsun Erdag, Mark E. Smolkin, et al.. (2016). PD-L1, PD-L2 and PD-1 expression in metastatic melanoma: Correlation with tumor-infiltrating immune cells and clinical outcome. OncoImmunology. 5(11). e1235107–e1235107. 103 indexed citations
11.
Benamar, Mouadh, Fadila Guessous, Joseph M. Obeid, et al.. (2016). Inactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanoma. EBioMedicine. 10. 85–100. 58 indexed citations
12.
Takahashi, Kazuhiro, Joseph M. Obeid, Charlotte Burmeister, et al.. (2016). Intrahepatic Cholangiocarcinoma in the Liver Explant After Liver Transplantation: Histological Differentiation and Prognosis. Annals of Transplantation. 21. 208–215. 32 indexed citations
13.
Obeid, Joseph M., Yinin Hu, & Craig L. Slingluff. (2015). Vaccines, Adjuvants, and Dendritic Cell Activators—Current Status and Future Challenges. Seminars in Oncology. 42(4). 549–561. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026